Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > DNDN > Summary

Dendreon Corp.
(DNDN)

29.44USD   Up0.55 (1.90%)   
At 2:30AM IST
 Dendreon Corp. (NGM:DNDN) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 29.44USD
Trade Time:2:30AM IST
Change:Up0.55 (1.90%)
Prev Close:28.89
Open:29.16
Bid:29.25 x 200
Ask:29.49 x 200
1y Target Est:36.44
Day's Range:28.95 - 29.51
52wk Range:2.55 - 30.90
Volume:1,529,770
Avg Vol (3m):2,244,100
Market Cap:3.41B
P/E (ttm):N/A
EPS (ttm):-1.92
Div & Yield:N/A (N/A%)
Add DNDN to Portfolio   Download Data

HEADLINES

 
•This Stock Has Tremendous Upside - Motley Fool  - Wed 12:00AM
•5-Star Stocks Poised to Pop: ISTA Pharmaceuticals - Motley Fool  - Tue 8:14PM
•An Earnings Surprise of an Unusual Kind - Motley Fool  - Mon, Feb 8
•4 Winning Biotechs For Your Portfolio: Senior Analyst - CNBC  - Mon, Feb 8
•Is Biotech Back? - CNBC  - Mon, Feb 8
•[video] Is Biotech Back? - CNBC  - Mon, Feb 8
•There's No Such Thing as an ETF Bubble - TheStreet.com  - Mon, Feb 8
•4-Star Stocks Poised to Pop: Myriad Genetics - Motley Fool  - Thu, Feb 4
•Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference - PR Newswire  - Wed, Feb 3
•Ground Floor -- Going Up! - Motley Fool  - Wed, Feb 3
•Dendreon: To Short or Not to Short? - Seeking Alpha  - Tue, Feb 2
•Barron's: new drugs could help industry sales, shares - Reuters  - Mon, Feb 1
» More Headlines for DNDN...

ANALYST

 
EPS Est (next year) (Dec-09) :-1.68
EPS Est (in 2 years) (Dec-10) :-0.59
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.

» Full Company Profile